Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 8/13/2025Gracell Gains NMPA Approval to Advance GC012F into Light-Chain Amyloid...
  • 8/13/2025CTTQ Secures IND Acceptance from China's NMPA for Two Innovative Cance...
  • 8/13/2025Merck Halts NSCLC Development of MK-1308 Amid Partnership with China's...
  • 8/12/2025Akeso Doses First Patient in Phase III Trial of Ivonescimab
  • 8/8/2025Hengrui Launches Phase 3 Trial of Trastuzumab Rezetecan Combo for AGC
  • 8/8/2025Boan's Dulaglutide Biosimilar Secures NMPA Approval in China
  • 8/8/2025Dizal's Birelentinib Granted FDA Fast Track for Treatment-Resistant CL...
  • 8/8/2025AstraZeneca Expands Use of Fasenra in China
  • 8/8/2025Bio-Thera Launches Ambitious Triple-Immunotherapy Trial for Advanced S...
  • 8/8/2025Minghui's MHB042C Earns Green Light for Clinical Trials in Advanced So...
  • 8/6/2025Everest's Nefecon Won NMPA Approval for Poduction Expansion to Meet Ri...
  • 8/6/2025Global Pharma Bets on China's AI Biotech for Next-Gen Drug Discovery
  • 8/6/2025MediLink and Akeso Launch First ADC–Ivonescimab Combo Trial
  • 8/5/2025CSPC's Chemically Synthesized Semaglutide Injection Accepted for Revie...
  • 8/5/2025China Approves AstraZeneca's Ultomiris for AQP4+ NMOSD
  • 8/5/2025Innovent Secures FDA Clearance to Begin U.S. Trials for Oral GLP-1 Dru...
  • 8/5/2025MediLink and Akeso Launch First Clinical Trial Combining Ivonescimab w...
  • 8/4/2025Novartis Submits Zolgensma for Approval in China with Priority Review ...
  • 8/4/2025Alphamab's JSKN022 ADC Clears Major Regulatory Hurdle, Highlights Prec...
  • 8/4/2025China Grants First-Time Approval to Eight New Drugs in July 2025
  • 8/2/2025PD‑L1×VEGF Bispecific from ImmuneOnco Shows Strong Efficacy in China...
  • 8/1/2025Chipscreen's Brain-Penetrant Aurora B Selective Inhibitor Receives FDA...
  • 8/1/2025Shanghai UTC Therapeutics Secures FDA IND Clearance for Novel MSLN CAR...
  • 7/31/2025China Sees Surge in Drug Applications: 24 New Therapies Filed with NMP...
  • 7/31/2025Lee’s Subsidiary Wins Approval of Socazolimab for ES‑SCLC in China
  • 7/31/2025Alphamab's JSKN003 Wins Orphan and BTD Designations in Two Major Marke...
  • 7/30/2025China Approves Domestic CD19 CAR-T Therapy Hengkailai
  • 7/30/2025SPH Biothera Receives NMPA Clearance for CAR-T Therapy Targeting Refra...
  • 7/29/2025Pfizer Launches Landmark Pneumococcal Vaccine Trial in China, Pioneeri...
  • 7/29/2025Innovent Wins NMPA Clearance for IBI363 in Two New Cancer Trials
  • Page:10/22 Total number of articles:631: [First][<<] [8] [9] [10] [11] [12] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group